Search

for
Search:

Sort by

Research

480-510 / 1000+ results

research EFECTO DE LA TESTOSTERONA, 4-HIDROXIANDROSTENDIONA Y FINASTERIDE SOBRE LA HEMOSTASIA EN UN MODELO DE ISQUEMIA/REPERFUSION CORONARIA EN RATA

November 2008

Testosterone, 4-hydroxyandrostenedione, and finasteride affect blood clotting differently in stressed heart conditions.

research Abstract 153: Inhibition of the 5-a-reductase Reduces Cardiac Hypertrophy and Improves Cardiac Function

August 2013 in “Circulation Research”

Finasteride reduces heart enlargement and improves heart function.

research Finasteride, a 5alpha-reductase enzyme inhibitor, alone and synergism with a neurosteroid reduces responsiveness to nociceptive stimuli in male rat

April 2009 in “Journal of Pain”

Finasteride reduces pain in male rats and works better with testosterone.

research Clinical Pearls in Men's Health

1 citations , June 2010 in “Mayo Clinic Proceedings”

The conclusion is that individualized treatment and proper medication use are crucial in men's health, with specific recommendations for ED, BPH, and prostate cancer management.

research Effect of MK-386, a novel inhibitor of type 1 5 alpha-reductase, alone and in combination with finasteride, on serum dihydrotestosterone concentrations in men

7 citations , August 1996 in “The Journal of Clinical Endocrinology and Metabolism”

research Erectile dysfunction from mechanisms to medicines with a focus on the application of topical Minoxidil

February 2023 in “Sexual Medicine Reviews”

research Finasteride for recurrent priapism in children and adolescents: a report on 5 cases

12 citations , October 2012 in “International Braz J Urol”

Finasteride effectively and safely treats recurrent priapism in children and adolescents with sickle cell disease.

Long-Term Dutasteride Therapy in Men with Benign Prostatic Hyperplasia Alters Glucose and Lipid Profiles and Increases Severity of Erectile Dysfunction

research Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction

20 citations , June 2017 in “Hormone Molecular Biology and Clinical Investigation”

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

research Effect of 5-alpha reductase inhibitors in animal models of Parkinson’s disease

September 2024 in “Frontiers in Neuroendocrinology”

5-alpha reductase inhibitors may help protect the brain and gut in Parkinson's disease.

research Why would men use finasteride in 2005?

December 2005 in “Current Prostate Reports”

In 2005, men used finasteride mainly to treat an enlarged prostate.

research Novel 5α-reductase inhibitors unlinked to depression-like phenotypes in rat model of BPH

April 2026 in “The Journal of Steroid Biochemistry and Molecular Biology”

research Risk assessment of the top 60 drugs for drug-related sexual dysfunction: a disproportion analysis from the Food and Drug Administration adverse event reporting system

August 2025 in “The Journal of Sexual Medicine”

Finasteride, dutasteride, and silodosin have the highest risk for causing sexual dysfunction.

Poria Cocos Polysaccharides Attenuate Chronic Nonbacterial Prostatitis by Targeting the Gut Microbiota: Comparative Study of Poria Cocos Polysaccharides and Finasteride in Treating Chronic Prostatitis

research Poria cocos polysaccharides attenuate chronic nonbacterial prostatitis by targeting the gut microbiota: Comparative study of Poria cocos polysaccharides and finasteride in treating chronic prostatitis

12 citations , August 2021 in “International Journal of Biological Macromolecules”

Poria cocos polysaccharides and finasteride both help treat chronic nonbacterial prostatitis, but Poria cocos polysaccharides also improve gut health.

Tamsulosin Treatment for Benign Prostatic Hyperplasia and Risk of Severe Hypotension in Men Aged 40-85 Years in the United States: Risk Window Analyses Using Between and Within Patient Methodology

research Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40-85 years in the United States: risk window analyses using between and within patient methodology

70 citations , November 2013 in “The BMJ”

Tamsulosin for enlarged prostate may increase the risk of severe low blood pressure, especially when starting or restarting the medication.

research The effect of polyphloretin phosphate, polyoestradiol phosphate, a diphosphonate and a polyphosphate on calcification induced by dihydrotachysterol in skin, aorta and kidney of rats

31 citations , February 1972 in “Experientia”

The diphosphonate was the most effective at preventing calcification in rats.

research Drug–Drug Coamorphous System of Tadalafil and Finasteride for Enhanced Pharmaceutical Performance

December 2025 in “Molecular Pharmaceutics”

Combining tadalafil and finasteride improves their solubility and effectiveness.

research Determination of the potency of a novel saw palmetto supercritical CO2 extract (SPSE) for 5α-reductase isoform II inhibition using a cell-free in vitro test system

3 citations , April 2016 in “Research and reports in urology”

The new saw palmetto extract effectively inhibits an enzyme linked to prostate enlargement and may be as good as standard treatments.

research Discovery and Clinical Development of Dutasteride, a Potent Dual 5α- Reductase Inhibitor

58 citations , March 2006 in “Current topics in medicinal chemistry”

Dutasteride effectively treats benign prostatic hyperplasia and may reduce prostate cancer risk.

research Understanding the role of prostaglandin E2 in regulating human platelet activity in health and disease

35 citations , May 2015 in “Thrombosis Research”

Prostaglandin E2 affects human platelet activity in complex ways that could lead to personalized heart disease treatments.

A New Look at the 5-Alpha-Reductase Inhibitor Finasteride

research A New Look at the 5?-Reductase Inhibitor Finasteride

137 citations , March 2006 in “Cns Drug Reviews”

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

research 5α-reductase activity in the prostate

237 citations , December 2001 in “Urology”

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

research A New Look at the 5á-Reductase Inhibitor Finasteride

January 2006

Finasteride, a medication, is being re-evaluated for its effects and uses.

Long-Term Oral Administration of 5α-Reductase Inhibitor Attenuates Erectile Function by Inhibiting Autophagy and Promoting Apoptosis of Smooth Muscle Cells in Corpus Cavernosum of Aged Rats

research Long-term Oral Administration of 5α-reductase Inhibitor Attenuates Erectile Function by Inhibiting Autophagy and Promoting Apoptosis of Smooth Muscle Cells in Corpus Cavernosum of Aged Rats

34 citations , September 2013 in “Urology”

Long-term use of a certain medication can worsen erectile function in aged rats by damaging penile muscle cells.

research Efficacy observation of tamsulosin combined finasteride on delay and prevention the progression of BPH

January 2011

Tamsulosin and finasteride together effectively slow down and prevent BPH progression.

5α-Reductase Inhibitors and Male Reproduction

research 5α-Reductase Inhibitors (5ARIs) and Male Reproduction

15 citations , January 2017 in “Advances in Experimental Medicine and Biology”

5α-Reductase inhibitors can negatively affect male sexual function and, in some cases, significantly reduce sperm count, but these effects may be reversible.

research 332 Recognizing and Treating Undiagnosed Erectile Dysfunction (ED) in Patients Presenting With Lower Urinary Tract Symptoms (LUTS)

December 2016 in “The journal of sexual medicine”

Many patients with lower urinary tract symptoms also have undiagnosed erectile dysfunction, which improves with treatment.

research Safety concerns regarding 5α reductase inhibitors for the treatment of androgenetic alopecia

33 citations , April 2015 in “Current Opinion in Endocrinology, Diabetes and Obesity”

5α reductase inhibitors treat hair loss but may cause sexual side effects and risks.

research Is finasteride intake associated with penile curvature/peyronie’s disease? Assessment of both the food and drug administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases

October 2021 in “European urology open science”

research A Randomized Placebo-Controlled Multicentre Study to Evaluate the Safety and Efficacy of Finasteride for Male Chronic Pelvic Pain Syndrome (Category IIIA Chronic Nonbacterial Prostatitis)

6 citations , March 2005 in “The Journal of Urology”

research Finasteride reduces the preventive effect of uroselective α1A-blockers against cancellous bone disorders induced by androgen deficiency in rats

July 2015 in “Pharmacological Reports”

Finasteride weakens the bone-protective effects of certain blockers in low androgen conditions.

← Previous page Next page →